HROMC GRANULOMATOUS disease (CGD) is a heterogeneous group of disorders arising from molecular lesions in the genes encoding a phagocyte-specific enzyme system, the NADPH-oxidase. ' The importance of the system to host immunity is exemplified by the clinical phenotype arising from its defective function, which is characterized by recurrent bacterial and fungal infection? Long-term prophylaxis with antibiotics and, in some cases, subcutaneous y-interferon may reduce the frequency of serious infections, but morbidity and early mortality remain significant. Bone marrow transplantation can be curative, but the paucity of suitable donor material and the increased risks and complications associated with use of matched unrelated donor grafts restricts application of this procedure to a minority of cases.
Expression of the NADPH-oxidase is largely restricted to phagocytic cells but may also be found in some subpopulations of B lymphocytes and B lymphocytes immortalized in vitro by Epstein-Barr virus (EBV). The major components of the NADPH-oxidase implicated in CGD are a membranebound flavocytochrome b558, composed of two subunits, ~2 2~~" and gp91Ph", and two cytosolic factors, p47ph0x and p67phf'x, which translocate to the membrane when the cell is a~tivated.~
The genes encoding both subunits of the flavocytochrome b558 and both cytosolic factors have now been c10ned.~"~ Overall, approximately two thirds of all patients have molecular lesions at CYBB, the X-linked genetic locus for gp9lPhoX that are unique to individual families in more than 90% of cases. The remaining patients have autosomal recessive disease, of which the majority are homozygous for a GT dinucleotide deletion at a GTGT dinucleotide repeat in the gene encoding p47ph".'0
For the reasons outlined above, CGD is an excellent candidate disorder for somatic gene therapy. Our group and other groups have shown the feasibility of this approach using retrovirus-mediated gene transfer to reconstitute NADPHoxidase activity in immortalized B cells derived from patients and mature phagocytic cells derived in vitro from transduced progenitor popu1ations."-l5 However, the inability of current vector systems that are based on murine retroviruses to efficiently transduce relatively quiescent cells such as the pluripotent hematopoietic stem cells (PHSCs) greatly restricts their potential to effect a permanent cure. One particularly attractive gene delivery system that is less dependent on cell cycle for successful transduction is based on the dependovirus, adeno-associated virus (AAV).I6 AAV is a member of a family of small nonenveloped icosahedral single-stranded DNA viruses, the parvoviruses. Although autonomous viruses such as human parvovirus B19 are dependent on cell division for their replication and are the cause of a number of diseases, the Dependoviruses require coinfection with helper viruses, usually adenovirus or herpes virus, for efficient replication and propagation during the lytic phase of the viral life cycle and are not known to be associated with human disease. In the absence of helper function, AAV establishes a latent infection by integration into the cellular genome." Recombinant AAV (rAAV) vectors have successfully been used to transduce a wide range of cell lines and primary cells, including CD34+ cells derived from human cord and recently have been used to show phenotypic correction of primary human hematopoietic progenitor cells derived from a patient with Fanconi anaemia. 22 We report the first demonstration of stable phenotypic correction of cells derived from a CGD patient by rAAV gene transfer. (Fig I) . AAV Generation of rAAV. rAAV particles were generated as previously described." 293 cells (5 X 10' ) were plated on 9-cm tissue culture dishes. Sixteen to 24 hours later, cells were infected with adenovirus type S at a multiplicity of infection (MOI) of S to 10. After a further 2 to 4 hours, cells were transfected with 10 pg each of vector (pAICH1.47) and helper (pABal) by calcium phosphate coprecipitation. At completion of the cytopathic effect 48 to 72 hours later, cells were harvested, subjected to four freeze and thaw cycles, and heated to 56°C for 1 hour to inactivate adenovirus. Debris was separated from the virus-containing supernatant by centrifugation at 4,000 rpm for 10 minutes. Mock supernatant was generated in the same way except that the helper plasmid (pABal) was omitted from the initial transfection. A crude estimate of virus titer (1 to S X lo4 transducing particles/mL) was obtained by slot-blot hybridization of viral DNA." The absence of contaminating wtAAV in the recombinant supernatants was demonstrated by probing the same blots for AAV rep gene sequences (data not shown).
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MATERIALS AND METHODS
Construction of rAAV plasmids
rAAV transduction of immortalized B lymphocytes. Cells were harvested and washed two times with phosphate-buffered saline (PBS). Viable cells (IO5) were resuspended in 2 mL of rAAV supernatant for 4 hours before being centrifuged at low speed and were washed once with PBS. Finally, the cells were resuspended in fresh RPM11640 medium and cultured for 4 weeks before initial analysis. As a control, the same number of cells were subjected to a sham infection using mock supernatant.
Detection of NADPH-oxidase activity. For luminometric determination of NADPH oxidase activity, 2 X 10' viable cells (determined by Trypan Blue staining) were harvested from the culture and Western blot analysis. Cells were disrupted by sonication. Crude protein extracts from equal numbers of cells were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on a 12.5% polyacrylamide gel and transferred to nitrocellulose (Hybond C; Amersham, Arlington Heights, IL). Blots were incubated with a polyclonal rabbit antiserum raised against the Cterminal 13 amino acids of ~47"'"~, as described previously," and reacting bands were visualised by ECL (Amersham).
Southern blot analysis. Genomic DNA samples (10 pg) were digested overnight with Xba I (2 UIpg), separated on a 1% agarose gel, and transferred to a nylon membrane (Hybond N+; Amersham).
Hybridization was performed at 42°C in buffer containing SO% formamide, using a 32P-labeled ~4 7 "~' " cDNA probe. Blots were washed to a final stringency of 2X SSC, 0.1% SDS at 65°C and autoradiographed for 24 hours with intensifying screens.
RESULTS
Generation of superoxide by transduced cells (Fig  2) . EBV-immortalized B lymphocytes express all components of the NADPH-oxidase and produce measurable quantities of superoxide after stimulation by agents such as PMA. Cells derived from patients with CGD mirror the functional defect of primary phagocytic cells and are useful models for reconstitution of oxidase activity by gene tran~fer.'~ EBV-immortalized B-cell lines derived from 2 patients with known ~47"~"'-deficient CGD were therefore used to test the ability of rAAV to restore function. In these experiments, production of superoxide was measured indirectly by a chemiluminescent assay for hydrogen peroxide, which is formed as a result of peroxidase-catalyzed dismutation.
At 2 and 3 months posttransduction, cells were harvested and assayed as described in Materials and Methods. Cells from exposed to a mock virus preparation produced levels of superoxide indistinguishable from those of activated unmanipulated cells. In contrast, ~47"~"'-deficient cells derived from both patients and infected with rAAV encoding p47pk''x produced low but significant levels compared with cells derived from a normal individual. Given the low titers of recombinant virus, transduction would appear to be relatively efficient. As a crude estimate for the number of reconstituted cells, approximately 1% of the same number of normal cells generate similar levels of superoxide. Assuming that the CMV promoter produces optimal levels of p47p"0*, this would suggest that an MO1 of between 10 and 1 0 0 would be required for successful transduction of all cells (data not shown).
More importantly, the degree of reconstitution remained stable for the 3-month period of investigation in the absence of selection for successfully transduced cells. Western blot analysis (Fig 3) . To confirm the presence of immunoreactive p47ph"x in transduced cell populations, extracts from B cells derived from a normal individual and from transduced and mock-transduced p47ph0"-deficient B cells, 3 months postinfection with rAAV, were reacted with a highly specific antiserum. Consistent with the degree of functional restoration, low levels of protein were detected in transduced cells when compared with normal. In contrast, immunoreactive protein was undetectable in mock-transduced cells. Although cells from both patients exhibited similar levels of functional reconstitution, a third patient cell line that had been exposed to the same rAAV supernatant and that expressed similar levels of protein to those shown above was consistently unable to produce detectable activity above background (data not shown). This finding reflects considerable heterogeneity in the ability of normal immortalized B-cell lines to produce superoxide, an observation that probably relects the maturation status of the cell.
Identijcation of rAAV genome in transduced cells (Fig  4) . At 3 months posttransduction, genomic DNA was extracted from cells derived from patient no. 2 (rAAV) and analyzed for the presence of the rAAV genome by Southern blotting. Only DNA from those cells that had been exposed to rAAV particles and had shown some reconstitution of NADPH-oxidase activity released a predicted 2.7-kb fragment after digestion with Xba I that hybridized specifically to a p47ph0.' cDNA probe. DNA extracted from cells derived from patient no. 1 at a similar time after transduction produced similar results, although the 2.7-kb hybridizing band was less distinct and is not shown. DNA from cells that underwent mock infection (mock) failed to generate this fragment under the same conditions, discounting the possibility that contaminating double-stranded plasmid originat- 
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DISCUSSION
CGD is an excellent candidate for the application of somatic gene therapy. Several groups have now described restoration of function to both immortalized cell lines and primary CD34' cells derived from patients with deficiencies of each of the major components of the NADPH-oxidase.""' However, the most widely applied vector system based on murine leukaemia retroviruses is severely limited by an inability to efficiently transduce the relatively quiescent PHSCs, which are probably only a minor subpopulation of CD34' bone marrow cells. This deficiency reflects a block to nuclear entry of the transducing genome imposed by the nuclear membrane, which is overcome at the time of cell di~ision.~' Strategies directed towards stimulation of stem cell proliferation in the absence of differentiation or development of gene transfer systems based on viruses such as human immunodeficiency virus (HIV) that encode specific nuclear localisation signals may overcome this problem, but are not currently applicable.2h
The human parvovirus, adeno-associated virus-2 (AAV-2). has many attributes that recommend its use as a gene transfer vehicle, including a broad tissue tropism, the ability to integrate stably into the host genome, and the potential for efficient infection of nondividing cells. Furthermore, although up to 90% of the population are seropositive, it is not known to cause human disease. We have shown for the first time that rAAV vectors can successfully and efficiently transduce cells derived from patients with CGD and, more importantly, can stably restore NADPH-oxidase function in the absence of selection. These results suggest that rAAV is an attractive vector system for somatic gene therapy of CGD. The ability of these vectors to restore function to primary hematopoietic progenitor cells is currently under investigation.
However, the wider application of rAAV gene transfer is at present limited by inefficient methods for the generation of transducing recombinant viral particles. These problems may be overcome by the development of packaging cell lines, similar in principle to those used to generate recombinant retroviruses, but has been problematical because of cellular toxicity of the AAV Rep proteins that are required for propagation of virus. Several groups have now constructed cell lines in which AAV helper functions are stably incorporated, either under the control of inducible pr~rnoters~'.*~ or the natural AAV promoters (Thrasher et al, unpublished data), but the ability of these lines to produce high-titer rAAV is not yet known. Although inefficient accumulation of packageable single-stranded species of the AAV genome may be limiting in some circumstance^^^ (Thrasher et For personal use only. on August 30, 2017. by guest www.bloodjournal.org From
